Seed Innovations Limited GBP · LSE:SEED

Seed Innovations Limited GBP — Fast Forward Innovations — Investor Presentation (2021)

21 slides from Seed Innovations Limited GBP's investor presentation, Mar 3, 2021

  1. Slide 1: Funding innovations to create future solutions

    OVERVIEW THE TEAM STRATEGY PORTFOLIO Funding innovations to create future solutions THE MARKET Corporate Presentation - H1 2021 SUMMARY CONTACT 1

  2. Slide 2: Disclaimer

    OVERVIEW Disclaimer TEAM TEAM This presentation and any additional documents handed out at any meeting or provided directly to potential investors (together the “Presentation Materials”) have not been approved by: (i) the London Stock Exchange plc or by any authority which could be a competent autho

  3. Slide 3: Overview

    OVERVIEW Overview TEAM TEAM STRATEGY PORTFOLIO STRATEGY PORTFOLIO AIM listed, closed end, investment Balance of early stage opportunities Track record of delivering real returns fund, regulated by the Guernsey that have an upcoming investment in medical cannabis, cannabinoid Financial Services Commi

  4. Slide 4: Key Data

    OVERVIEW Key Data TEAM TEAM Notable Shareholders Investor Number of Shares % of Issued Share STRATEGY PORTFOLIO STRATEGY Capital Mrs Rhonda Abony 17,784,388 8.36 Share price: Mkt. Cap: Peter Saladino 17,194,590 8.08 12.15p £27.66m PORTFOLIO Jim Mellon 16,283,722 7.65 Richard Hackett 9,17,478 4.61 PO

  5. Slide 5: Board

    OVERVIEW Board TEAM TEAM Ed McDermott Lance de Jersey STRATEGY Chief Executive Officer Financial Director PORTFOLIO STRATEGY Ed has over 15 years’ experience in the management, financing and Lance is member of the Institute of Chartered Secretaries and Administrators development of SMEs across variou

  6. Slide 6: Investment Approach

    OVERVIEW Investment Approach TEAM TEAM 1 Identify, undertake rigorous due diligence and invest in a balanced portfolio of early stage opportunities that have an upcoming investment STRATEGY PORTFOLIO STRATEGY catalyst such as an IPO, potential re-rating or acquisition as well as more mature investme

  7. Slide 7: Portfolio Overview

    OVERVIEW Portfolio Overview TEAM TEAM Medical Cannabis & Life Sciences Technology STRATEGY PORTFOLIO STRATEGY Cannabinoid Wellness & Biotech & Fintech PORTFOLIO Life Sciences, CBD & Life Sciences, CBD & Life Sciences, CBD & PORTFOLIO Wellness Wellness Wellness MARKET MARKET SUMMARY SUMMARY APPENDIX

  8. Slide 8: Portfolio Overview: Liquid Investments

    OVERVIEW Portfolio Overview Liquid Investments TEAM TEAM Portage Biotech Inc. www.portagebiotech.com • Supports nine subsidiary companies focused on cutting edge R&D to treat various cancers, eye disease and acute kidney injury • Experienced team with track record of developing five separate billion

  9. Slide 9: Portfolio Overview: Pre-Liquidity Investments

    OVERVIEW Portfolio Overview Pre-Liquidity Investments TEAM TEAM EMMAC Life Sciences Plc www.emmac.com STRATEGY • Europe’s largest medical cannabis company, which brings together cutting-edge scientific research PORTFOLIO STRATEGY with the latest innovations in cannabis, controlling the entire lifecy

  10. Slide 10: Portfolio Overview: Longer Term Investments

    OVERVIEW Portfolio Overview Longer Term Investments TEAM TEAM STRATEGY PORTFOLIO STRATEGY South West Brands www.southwestbrands.co • London-based, group that is seeking to establish itself as a multi-brand consumer goods group developed specifically for the CBD industry • Female-led, world-class tea

  11. Slide 11: Potential Investments

    OVERVIEW Potential Investments TEAM TEAM New or follow-on investments in medical STRATEGY PORTFOLIO STRATEGY cannabis and cannabinoid wellness – recent FCA guidance enables increased focus and activity in this space which has already been PORTFOLIO seen Opportunities include highly scalable PORTFOLI

  12. Slide 12: Trending Markets

    OVERVIEW Trending Markets TEAM TEAM Demand for cannabinoid wellness outstrips supply in most markets STRATEGY PORTFOLIO STRATEGY Growth Drivers International Cannabis Legal Status of Medical Cannabis Market: • The global legal cannabis market size is PORTFOLIO • Increasing market acceptance expected

  13. Slide 13: Focus on High-Growth Markets

    OVERVIEW Focus on High-Growth Markets TEAM TEAM The market for ‘techmanity’, which is The overall virtual reality in gaming and technology to increase human lifespan, entertainment market is expected to grow from STRATEGY PORTFOLIO STRATEGY is worth USD $110Bn today, growing at a US$4.15 Billion in

  14. Slide 14: Investment Case

    OVERVIEW Investment Case TEAM TEAM Balanced, actively managed, multi-sector / jurisdiction portfolio now targeting exclusively fast-growing medical cannabis arena STRATEGY PORTFOLIO STRATEGY Only AIM listed company that has made investments directly into medical cannabis PORTFOLIO Robust pipeline of

  15. Slide 15: Appendix

    Appendix 15 CONTACT SUMMARY THE MARKET PORTFOLIO STRATEGY THE TEAM OVERVIEW

  16. Slide 16: Recent Portfolio News

    OVERVIEW Recent Portfolio News TEAM TEAM January 2021 February 2021 February 2021 February 2021 EMMAC and Yooma Leap Gaming develops Portage announces 2021 FastForward invests enter into licensing an innovative new research and £62,500 in Kanabo Group STRATEGY agreement whereby betting product, deve

  17. Slide 17: Case Study

    OVERVIEW Case Study TEAM TEAM Proven strategy that delivers financial gains STRATEGY PORTFOLIO STRATEGY MARCH 2017 2017 MARCH 2018 JUNE 2018 PORTFOLIO C$3m seed Supported and Sold to publicly investment in advised team to traded Aphria PORTFOLIO Canadian strengthen in resulting in 4.8X cash underlyi

  18. Slide 18: Supporting Growth: EMMAC Life Sciences

    OVERVIEW Supporting Growth TEAM TEAM EMMAC Life Sciences – The Leading European Cannabis Company STRATEGY PORTFOLIO STRATEGY Highlights Raised £35m in first 12 months of operations, more than any other private European cannabis company and further £15 million in December ‘20 PORTFOLIO Owned and acti

  19. Slide 19: Supporting Growth: EMMAC End-to-end Control

    OVERVIEW Supporting Growth TEAM TEAM EMMAC Life Sciences - End-to-end Control Of Medical Cannabis Supply Chain STRATEGY PORTFOLIO STRATEGY PORTFOLIO RESEARCH CULTIVATION PROCESSING DISTRIBUTION PORTFOLIO & • Own medical cannabis • Good distribution • 2 operation EU-GMP MARKET DEVELOPMENT MARKET bran

  20. Slide 20: Supporting Growth: Leap Gaming

    OVERVIEW Supporting Growth TEAM TEAM Leap Gaming – B2B Developer of High-end Gaming Applications STRATEGY PORTFOLIO STRATEGY Highlights Virtual sports and casino applications generating tens of thousands of engagement points with end-users. PORTFOLIO State-of-the-art technologies with 3D generation

  21. Slide 21: OVERVIEW PORTFOLIO STRATEGY PORTFOLIO

    TEAMOVERVIEW TEAM STRATEGY PORTFOLIO STRATEGY 11 New Street PORTFOLIO St Peter Port Guernsey PORTFOLIO GY1 3EG www.fstfwd.co MARKET MARKET ir@fstfwd.co SUMMARY SUMMARY APPENDIX Corporate Presentation - H1 2021 21

Fast Forward Innovations — Investor Presentation (2021) on 6ix